The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are: * Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT? Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.
Study Type
OBSERVATIONAL
Enrollment
75
Royal Free Hospital
London, United Kingdom
Track the adherence of DistaSense
To evaluate the adherence of patients using DistaSense, a non-contact vital sign monitor that measures heart rate and respiration rate, we will be tracking the patient dropout rate over the course of the 12 month study period.
Time frame: 12 months
Understand the patient acceptance of DistaSense
To evaluate the patient acceptance of using DistaSense, a non-contact vital sign monitor that measures heart rate and respiration rate, we will be requesting patients complete a Technology Assessment Model Fast Form (TAM-FF) every 3 months during the 12 month trial period.
Time frame: 12 months
Ability to detect COPD exacerbations
To evaluate the ability of a non-contact remote monitoring techniques to detect exacerbations of COPD.
Time frame: 3 - 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.